Migraine Clinical Trials in Philadelphia

Showing 1-20 of 130 trials

Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine

NCT01016834

The purpose of the study is to evaluate the treatment satisfaction of subjects using Sumavel DosePro to treat their moderate to severe migraines.

Migraine

Zogenix, Inc.246 participantsStarted Nov 2009

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Newport Beach, California, United States +18 more locations

RECRUITINGPhase 3< 1 mile

A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine

NCT07018713

In this clinical trial, participants with chronic migraine will receive injections with Xeomin or Placebo into muscles of the head and neck. The purpose is to measure the change in monthly migraine days with Xeomin injections compared to Placebo injections. Trial details include: * Trial duration: 52 to 55 weeks; * Screening period: 4 to 5 weeks; * Treatment duration: 4 treatments, each about 12 weeks apart; and * Visit frequency: about every 4 weeks, 14 visits in total. The first and last visit and the 4 treatment visits are on-site, the other 8 visits are remote by phone / video call.

Chronic Migraine

Merz Therapeutics GmbH780 participantsStarted Aug 2025

Chandler, Arizona, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +105 more locations

Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine

A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine

Migraine Trials in Other Cities

MMA Embolization for Refractory Chronic Migraine

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications

A Study to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents

Initiating Early Control of Migraine Pain and Associated Symptoms

Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine

Migraine Prevention With the Remote Electrical Neuromodulation (REN) Wearable: A Real-world Evidence Study

A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine

Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine

A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache

A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine

BE WELL With Migraine: Brain Education and WELLness With Migraine

Other Conditions in Philadelphia